We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett's Esophagus

By LabMedica International staff writers
Posted on 21 Oct 2013
Print article
Image: Barrett's esophagus (left part of image). The characteristic goblet cells are stained blue. Normal stratified squamous epithelium is seen on the right of the image (Photo courtesy of Wikimedia Commons).
Image: Barrett's esophagus (left part of image). The characteristic goblet cells are stained blue. Normal stratified squamous epithelium is seen on the right of the image (Photo courtesy of Wikimedia Commons).
Results obtained during a large genome-wide association study yielded three previously unknown gene associations linked to the risk of esophageal cancer and its precursor, Barrett's esophagus.

Esophageal cancer (more than 60% being esophageal adenocarcinoma) affects nearly 18,000 Americans annually with more than 15,000 fatalities. A precursor syndrome, Barrett's esophagus is associated with chronic heartburn and affects an estimated one to two million Americans each year.

Both syndromes are under active study by a group of investigators comprising the international Barrett's and Esophageal Adenocarcinoma Consortium, or BEACON, an open scientific forum for research into the causes and prevention of esophageal cancer and Barrett's esophagus that involves more than 40 scientists in North America, Europe, and Australia.

In a recent study, BEACON investigators at the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) pooled data and DNA specimens from 15 international studies conducted over the past 20 years to estimate the heritability of esophageal adenocarcinoma and Barrett's esophagus and identify genetic variants associated with increased risk. Ultimately, they gathered DNA samples and lifestyle risk-exposure data from more than 8,000 study participants, including about 5,500 with esophageal cancer or Barrett's esophagus and about 3,200 participants without these conditions who served as a control group. The DNA samples were genotyped using a high-density array platform that allowed for the simultaneous and accurate assessment of more than one million genetic variants.

Analysis of the data enabled the researchers to identify genetic variants at three locations – on chromosomes 3, 9 and 19. These variants were found to be associated significantly with esophageal adenocarcinoma and Barrett's esophagus. In addition, they found that a genetic variant on chromosome 16 that had been previously linked to Barrett's esophagus was also associated with an increased risk of esophageal adenocarcinoma.

"Epidemiologic findings, largely based on the work of BEACON investigators, clearly demonstrate that environmental factors such as obesity, gastroesophageal reflux, smoking, and diet are largely responsible for the rapidly increasing incidence and mortality from esophageal adenocarcinoma," said senior author Dr. Thomas L. Vaughan, professor of epidemiology at the Fred Hutchinson Cancer Research Center. "However, a growing body of evidence also suggests an important role for inherited susceptibility. These findings establish strong starting points for further epidemiologic studies to pin down the causal variants, and laboratory studies to identify the mechanisms by which the causal variants might affect the development of Barrett's esophagus and esophageal adenocarcinoma. The fact that all four of the new loci are in or near genes associated with early development of the esophagus or already associated with oncogenic activity is particularly exciting, as it implies that we may be close to finding some important pathways in the development of this highly fatal disease."

The study was published in the October 13, 2013, online edition of the journal Nature Genetics.

Related Links:

Fred Hutchinson Cancer Research Center


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Unit-Dose Packaging solution
HLX
New
Blood Culture Identification Fungal Pathogen Panel
cobas eplex BCID-FP panel
New
Sexually Transmitted Diseases Test
STD Panel Strip

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.